Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 21, 2022 - Issue 6: Safety associated with rapid acting antidepressants
Submit an article Journal homepage
7,056
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Can ketamine be a safe option for treatment-resistant bipolar depression?

Balwinder SinghDepartment of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7062-8192View further author information
ORCID Icon,
Jennifer L. Vande VoortDepartment of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USAView further author information
,
Mark A. FryeDepartment of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USAView further author information
&
Simon KungDepartment of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USAView further author information
Pages 717-720 | Received 30 Nov 2021, Accepted 18 Feb 2022, Published online: 28 Feb 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Omar H Elsayed, Mete Ercis, Mehak Pahwa & Balwinder Singh. (2022) Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions. Neuropsychiatric Disease and Treatment 18, pages 2927-2943.
Read now

Articles from other publishers (3)

Anna Feeney & George I. Papakostas. (2023) Pharmacotherapy. Psychiatric Clinics of North America 46:2, pages 277-290.
Crossref
Balwinder Singh. (2023) Ketamine for Treatment‐Resistant bipolar depression—A reality check! . Bipolar Disorders.
Crossref
Ashok Seshadri, Vishnu Sundaresh, Larry J. Prokop & Balwinder Singh. (2022) Thyroid Hormone Augmentation for Bipolar Disorder: A Systematic Review. Brain Sciences 12:11, pages 1540.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.